SCMP
Sucampo Pharmaceuticals, Inc.
Set alert
No live quote for SCMP yet.
- Open
- 18.00
- Prev close
- 18.00
- Mkt cap
- 847.54M
- Vol
- 303.07K
- Avg vol
- 3.45M
- EPS
- -3.37
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 17.95
- High
- 18.08
- Forward P/E
- 13.04
- Beta
- 0.58
- Short ratio
- 9.78
- Inst. own
- 82.47%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 17.99
- 200-d avg
- 13.81
- 1y target
- 17.40
Ownership
Held by insiders 35.13%
Held by institutions 82.47%
Float held by institutions 127.14%
Institutions 245
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 8.62% | 4,074,950 | 73.27M | Dec 30, 2017 |
| Lsv Asset Management | 5.23% | 2,471,718 | 44.44M | Dec 30, 2017 |
| Renaissance Technologies, LLC | 4.14% | 1,957,600 | 35.20M | Dec 30, 2017 |
| Paulson & Company, Inc. | 3.38% | 1,600,000 | 28.77M | Dec 30, 2017 |
| Dimensional Fund Advisors LP | 3.27% | 1,547,788 | 27.83M | Dec 30, 2017 |
| Vanguard Group, Inc. (The) | 3.25% | 1,536,333 | 27.62M | Dec 30, 2017 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Core S&P Smallcap ETF | 2.45% | 1,160,578 | 20.87M | Dec 30, 2017 |
| Vanguard Total Stock Market Index Fund | 1.81% | 858,104 | 8.92M | Jun 29, 2017 |
| iShares NASDAQ Biotechnology ETF | 1.34% | 634,498 | 11.41M | Dec 30, 2017 |
| Investment Managers Ser Tr-Vivaldi Merger Arbitrage Fd | 1.31% | 617,715 | 11.11M | Dec 30, 2017 |
| Royce Opportunity Fund | 1.08% | 512,670 | 6.00M | Sep 29, 2017 |
| iShares Russell 2000 ETF | 1.03% | 487,734 | 8.77M | Dec 30, 2017 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ALDER MATTHIAS | Officer | Acquisition (Non Open Market) | Jun 29, 2017 | 4,763 |
| BRYAN JONES W. | Officer | Acquisition (Non Open Market) | Dec 30, 2017 | 5,139 |
| DONLEY MATTHEW MAXWELL | Officer | Acquisition (Non Open Market) | Dec 30, 2017 | 36,975 |
| DRIGGS ALEX | Officer | Acquisition (Non Open Market) | Dec 30, 2017 | 6,084 |
| EDICK PAUL R | Director | Acquisition (Non Open Market) | May 31, 2017 | 14,930 |
| GETMAN DANIEL P | Director | Option Exercise | Nov 28, 2016 | 0 |